CLINICAL SUPPLY MANAGEMENT ARTICLES
How Investigational Product Supply Supports Reliable Clinical Trial Evidence
Investigational product availability, site-level handling, accountability and contingency planning all contribute to reliable clinical trial execution and evidence generation.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
Learn why the ability to get investigational products to sites, and appropriately store them, is not a given – and this oversight can have serious consequences.
-
Shipping and storing advanced therapeutics are complex processes, but advancements in accountability, wearables, and technology capture real-time factors critical to safety and protocol.
-
Expand your knowledge of IRT/RTSM systems and their capabilities to tailor supplies to site-specific recruitment, significantly decrease drug waste and costs, ensure efficient IMP management, and more.
-
DtP trials are a win-win for patients and sponsors. The purpose of this white paper is to provide in-depth information on the various DtP approaches while offering insight into best practices when incorporating DtP into the protocol.
-
How can a randomization and trial supply management approach to track and trace help improve its efficiency and efficacy? Find out the answer in this white paper.
-
Signant’s SmartSignals® RTSM solution helped an innovative biopharmaceutical company secure an FDA Orphan Drug designation for its cardiomyopathy drug.
-
How to incorporate flexibility in planning to overcome potential challenges, the value of having a contingency plan, and how a risk-based approach can determine where a contingency plan is needed.